MFS
CARM

Mirabella Financial Services’s Carisma Therapeutics CARM Stock Holding History

Mirabella Financial Services’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,418
Closed -$119K – 295
2020
Q4 		$119K Sell
4,418
-344
-7% -$8.72K 0.01% 276
2020
Q3 		$133K Buy
+4,762
New +$95.2K 0.02% 313

Other funds holding CARM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirabella Financial Services's CARM Position: Q1 2021 in Review

Mirabella Financial Services sold out of Carisma Therapeutics (CARM) in Q1 2021, closing a stake of 4,418 shares — an estimated $119K sold.

Mirabella Financial Services first reported a position in CARM in Q3 2020 and held it in 2 quarters. The position peaked at $133K in Q3 2020. 76 funds tracked by Wall St. Rank hold CARM as of Q1 2021.

  • Mirabella Financial Services reported no remaining Carisma Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Mirabella Financial Services sold 4,418 Carisma Therapeutics shares in Q1 2021, an estimated $119K.
  • Mirabella Financial Services first reported a position in Carisma Therapeutics in Q3 2020 and held it in 2 quarters.
  • Mirabella Financial Services's Carisma Therapeutics position peaked at $133K in Q3 2020.
  • 76 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2021.

Based on Mirabella Financial Services's 13F filing for Q1 2021, filed 17 May 2021.